tetraiodothyroacetic acid has been researched along with heteronemin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chang, WJ; Chen, YR; Chin, YT; Chu, HR; Davis, PJ; De Vito, P; Gionfra, F; Hsiung, CN; Huang, CH; Huang, HM; Huang, TY; Incerpi, S; Lee, SY; Li, ZL; Lin, CY; Lin, HY; Pan, YS; Pedersen, JZ; Unson, S; Wang, K; Whang-Peng, J | 1 |
Candelotti, E; ChangOu, CA; Chu, HR; Chung, CC; Davis, PJ; De Luca, R; Huang, CH; Huang, HM; Huang, TY; Incerpi, S; Lee, SY; Li, WS; Li, ZL; Lin, CY; Lin, HY; Pedersen, JZ; Wang, K; Whang-Peng, J; Yang, YSH | 1 |
2 other study(ies) available for tetraiodothyroacetic acid and heteronemin
Article | Year |
---|---|
Combined Treatment of Heteronemin and Tetrac Induces Antiproliferation in Oral Cancer Cells.
Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gingival Neoplasms; Humans; Terpenes; Thyroxine | 2020 |
Heteronemin and tetrac derivatives suppress non-small cell lung cancer growth via ERK1/2 inhibition.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Therapy, Combination; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Terpenes; Thyroxine | 2022 |